Taolin Yi

6.3k total citations · 3 hit papers
51 papers, 5.5k citations indexed

About

Taolin Yi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Taolin Yi has authored 51 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 37 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Taolin Yi's work include Protein Tyrosine Phosphatases (29 papers), Galectins and Cancer Biology (22 papers) and Cytokine Signaling Pathways and Interactions (21 papers). Taolin Yi is often cited by papers focused on Protein Tyrosine Phosphatases (29 papers), Galectins and Cancer Biology (22 papers) and Cytokine Signaling Pathways and Interactions (21 papers). Taolin Yi collaborates with scholars based in United States, Canada and Japan. Taolin Yi's co-authors include James N. Ihle, Bo Tang, Olli Silvennoinen, Frederick W. Quelle, Bruce A. Witthuhn, Osamu Miura, Karim Berrada, Eric O. Long, Deborah N. Burshtyn and Gerald Krystal and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Taolin Yi

51 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

1993 1.0k citations Bruce A. Witthuhn, Frederick W. Quelle et al. Cell profile →
Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene

1993 653 citations Taolin Yi, James N. Ihle et al. Cell profile →
Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor

1996 534 citations Deborah N. Burshtyn, Andrew M. Scharenberg et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taolin Yi United States	31	3.2k	2.7k	2.0k	593	461	51	5.5k
Hiroshi Wakao Japan	30	2.4k 0.8×	1.6k 0.6×	2.6k 1.3×	578 1.0×	353 0.8×	60	4.9k
Brian Gliniak United States	16	2.8k 0.9×	3.0k 1.1×	1.5k 0.7×	517 0.9×	184 0.4×	23	5.6k
Frank Grünebach Germany	38	2.4k 0.8×	1.8k 0.7×	1.3k 0.6×	646 1.1×	471 1.0×	73	4.2k
Selina Chen‐Kiang United States	47	1.9k 0.6×	3.4k 1.3×	2.6k 1.3×	1.1k 1.8×	869 1.9×	147	6.6k
Robert C. Rickert United States	40	3.8k 1.2×	2.6k 1.0×	1.2k 0.6×	358 0.6×	623 1.4×	81	6.4k
John P. McKearn United States	23	1.4k 0.4×	1.9k 0.7×	939 0.5×	514 0.9×	416 0.9×	56	3.7k
Colette Adida France	21	1.0k 0.3×	3.6k 1.3×	1.8k 0.9×	411 0.7×	294 0.6×	24	5.2k
Paul K. Pattengale United States	24	1.5k 0.5×	2.5k 0.9×	2.1k 1.1×	827 1.4×	632 1.4×	57	5.8k
Matthew L. Thomas United States	38	4.9k 1.5×	3.2k 1.2×	1.1k 0.5×	220 0.4×	199 0.4×	64	6.9k
Takeshi Tsubata Japan	37	4.2k 1.3×	1.8k 0.7×	660 0.3×	266 0.4×	358 0.8×	126	5.7k

Countries citing papers authored by Taolin Yi

Since Specialization

Citations

This map shows the geographic impact of Taolin Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taolin Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taolin Yi more than expected).

Fields of papers citing papers by Taolin Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taolin Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taolin Yi. The network helps show where Taolin Yi may publish in the future.

Co-authorship network of co-authors of Taolin Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Taolin Yi. A scholar is included among the top collaborators of Taolin Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taolin Yi. Taolin Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kundu, Suman, et al.. (2010). Novel SHP-1 Inhibitors Tyrosine Phosphatase Inhibitor-1 and Analogs with Preclinical Anti-Tumor Activities as Tolerated Oral Agents. The Journal of Immunology. 184(11). 6529–6536. 60 indexed citations

Yi, Taolin, et al.. (2010). PRL-2 increases Epo and IL-3 responses in hematopoietic cells. Blood Cells Molecules and Diseases. 44(4). 209–214. 7 indexed citations

Borden, Ernest C., et al.. (2009). Interferon-γ Is Induced in Human Peripheral Blood Immune Cells In Vitro by Sodium Stibogluconate/Interleukin-2 and Mediates Its Antitumor Activity In Vivo. Journal of Interferon & Cytokine Research. 29(8). 451–459. 11 indexed citations

Yi, Taolin & Daniel J. Lindner. (2008). The role and target potential of protein tyrosine phosphatases in cancer. Current Oncology Reports. 10(2). 114–121. 25 indexed citations

Li, Jing, Daniel J. Lindner, Carol Farver, Ernest C. Borden, & Taolin Yi. (2006). Efficacy of SSG and SSG/IFNα2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action. Cancer Chemotherapy and Pharmacology. 60(3). 341–349. 5 indexed citations

Leaman, Douglas W., Mamta Chawla‐Sarkar, Barbara Jacobs, et al.. (2003). Novel Growth and Death Related Interferon-Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN- β Compared with IFN- α 2. Journal of Interferon & Cytokine Research. 23(12). 745–756. 105 indexed citations

Dhawan, Deepika, et al.. (2002). Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.. PubMed. 1(14). 1255–64. 103 indexed citations

Yi, Taolin, et al.. (2002). Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs. The Journal of Immunology. 169(10). 5978–5985. 56 indexed citations

Dong, Fan, et al.. (2001). The Carboxyl Terminus of the Granulocyte Colony- Stimulating Factor Receptor, Truncated in Patients with Severe Congenital Neutropenia/Acute Myeloid Leukemia, Is Required for SH2-Containing Phosphatase-1 Suppression of Stat Activation. The Journal of Immunology. 167(11). 6447–6452. 51 indexed citations

10.

Yi, Taolin, et al.. (2001). Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines. The Journal of Immunology. 167(6). 3391–3397. 164 indexed citations

11.

Umeda, Syuji, Wesley G. Beamer, Katsumasa Takagi, et al.. (1999). Deficiency of SHP-1 Protein-Tyrosine Phosphatase Activity Results in Heightened Osteoclast Function and Decreased Bone Density. American Journal Of Pathology. 155(1). 223–233. 61 indexed citations

12.

Wickrema, Amittha, Shahab Uddin, Arun K. Sharma, et al.. (1999). Engagement of Gab1 and Gab2 in Erythropoietin Signaling. Journal of Biological Chemistry. 274(35). 24469–24474. 89 indexed citations

13.

Binstadt, Bryce A., Daniel D. Billadeau, Dragan Jevremović, et al.. (1998). SLP-76 Is a Direct Substrate of SHP-1 Recruited to Killer Cell Inhibitory Receptors. Journal of Biological Chemistry. 273(42). 27518–27523. 106 indexed citations

14.

Xu, Xiang‐Xi, Taolin Yi, Bo Tang, & J. David Lambeth. (1998). Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2. Oncogene. 16(12). 1561–1569. 105 indexed citations

15.

Uddin, Shahab, Isabella M. Grumbach, Taolin Yi, Oscar R. Colamonici, & Leonidas C. Platanias. (1998). Interferon α activates the tyrosine kinase Lyn in haemopoietic cells. British Journal of Haematology. 101(3). 446–449. 12 indexed citations

16.

Yi, Taolin, et al.. (1997). Selective Reporter Expression in Mast Cells Using a Chymase Promoter. Journal of Biological Chemistry. 272(5). 2969–2976. 13 indexed citations

17.

Burshtyn, Deborah N., Andrew M. Scharenberg, Nicolai Wagtmann, et al.. (1996). Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor. Immunity. 4(1). 77–85. 534 indexed citations breakdown →

18.

Tang, Bo, Hiroyuki Mano, Taolin Yi, & James N. Ihle. (1994). Tec Kinase Associates with c-kit and Is Tyrosine Phosphorylated and Activated following Stem Cell Factor Binding. Molecular and Cellular Biology. 14(12). 8432–8437. 91 indexed citations

19.

Witthuhn, Bruce A., Frederick W. Quelle, Olli Silvennoinen, et al.. (1993). JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74(2). 227–236. 1030 indexed citations breakdown →

20.

Yi, Taolin, Debra J. Gilbert, Nancy A. Jenkins, Neal G. Copeland, & James N. Ihle. (1992). Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6. Genomics. 14(3). 793–795. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact